Litcius/Paper detail

A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates

Sofia Banu, Bani Jolly, Payel Mukherjee, Priya Singh, Shagufta Khan, Lamuk Zaveri, Sakshi Shambhavi, Namami Gaur, Shashikala Reddy, K. Kaveri, Sivasubramanian Srinivasan, Dhinakar Raj Gopal, Archana Bharadwaj Siva, Kumarasamy Thangaraj, Karthik Bharadwaj Tallapaka, Rakesh K. Mishra, Vinod Scaria, Divya Tej Sowpati

2020Open Forum Infectious Diseases81 citationsDOIOpen Access PDF

Abstract

BACKGROUND: From an isolated epidemic, coronavirus disease 2019 has now emerged as a global pandemic. The availability of genomes in the public domain after the epidemic provides a unique opportunity to understand the evolution and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus across the globe. METHODS: We performed whole-genome sequencing of 303 Indian isolates, and we analyzed them in the context of publicly available data from India. RESULTS: We describe a distinct phylogenetic cluster (Clade I/A3i) of SARS-CoV-2 genomes from India, which encompasses 22% of all genomes deposited in the public domain from India. Globally, approximately 2% of genomes, which to date could not be mapped to any distinct known cluster, fall within this clade. CONCLUSIONS: variants per site per year, which is lower than the prevalent A2a cluster. Epidemiological assessments suggest that the common ancestor emerged at the end of January 2020 and possibly resulted in an outbreak followed by countrywide spread. To the best of our knowledge, this is the first comprehensive study characterizing this cluster of SARS-CoV-2 in India.

Topics & Concepts

CladePhylogenetic treeOutbreakContext (archaeology)GenomePandemicPhylogeneticsCluster (spacecraft)CoronavirusBiologyEvolutionary biologyVirologyGeneticsMedicineCoronavirus disease 2019 (COVID-19)DiseaseGeneInfectious disease (medical specialty)PaleontologyProgramming languageComputer sciencePathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies